 | • レポートコード：MRC2-11QY04405 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は偽腫瘍セレブリのグローバル市場について調査・分析したレポートです。種類別（眼底検査、ニューロ画像、腰椎穿刺）市場規模、用途別（髄液シャント、視神経鞘開窓、静脈洞ステント留置、投薬）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別偽腫瘍セレブリの競争状況、市場シェア ・世界の偽腫瘍セレブリ市場：種類別市場規模 2015年-2020年（眼底検査、ニューロ画像、腰椎穿刺） ・世界の偽腫瘍セレブリ市場：種類別市場規模予測 2021年-2026年（眼底検査、ニューロ画像、腰椎穿刺） ・世界の偽腫瘍セレブリ市場：用途別市場規模 2015年-2020年（髄液シャント、視神経鞘開窓、静脈洞ステント留置、投薬） ・世界の偽腫瘍セレブリ市場：用途別市場規模予測 2021年-2026年（髄液シャント、視神経鞘開窓、静脈洞ステント留置、投薬） ・北米の偽腫瘍セレブリ市場分析：米国、カナダ ・ヨーロッパの偽腫瘍セレブリ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの偽腫瘍セレブリ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の偽腫瘍セレブリ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの偽腫瘍セレブリ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Avkare, Inc.、B. Braun Melsungen AG、Beckersmith Medical, Inc.、Elekta AB、Heritage Pharmaceuticals Inc.、Ingenus Pharmaceuticals、Integra LifeSciences Corporation、Johnson & Johnson Services, Inc.、Lannett Company, Inc.、Magstim、Medtronic、MercuryPharma、Nostrum Laboratories Inc.、Novast Holdings Ltd.、Phoenix Biomedical Corp.、Sanofi, SGPharma Pvt. Ltd.、Sophysa、Taro Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、West-Ward Pharmaceutical、Zydus Pharmaceuticals, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Pseudotumor Cerebri, also known as idiopathic intracranial hypertension (IIH) is a syndrome of elevated intracranial pressure (ICP) that occurs predominantly in obese women of childbearing age. Headaches and vision impairment are most commonly found in patients with Pseudotumor Cerebri. The visual symptoms may arise due to papilledema.
Asia Pacific is the fastest growing pseudotumor cerebri market owing to a huge patient pool and development in healthcare technology. Healthcare expenditure is found to be boosting in various regions of Asia Pacific.
Market Analysis and Insights: Global Pseudotumor Cerebri Market
The global Pseudotumor Cerebri market size is projected to reach US$ 9347.3 million by 2026, from US$ 8872 million in 2020, at a CAGR of 5.0%% during 2021-2026.
Global Pseudotumor Cerebri Scope and Market Size
Pseudotumor Cerebri market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pseudotumor Cerebri market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Avkare, Inc.
B. Braun Melsungen AG
Beckersmith Medical, Inc.
Elekta AB
Heritage Pharmaceuticals Inc.
Ingenus Pharmaceuticals
Integra LifeSciences Corporation
Johnson & Johnson Services, Inc.
Lannett Company, Inc.
Magstim
Medtronic
MercuryPharma
Nostrum Laboratories Inc.
Novast Holdings Ltd.
Phoenix Biomedical Corp.
Sanofi, SGPharma Pvt. Ltd.
Sophysa
Taro Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
West-Ward Pharmaceutical
Zydus Pharmaceuticals, Inc.
Market segment by Type, the product can be split into
Fundoscopy
Neuroimaging
Lumbar Puncture
Market segment by Application, split into
Spinal Fluid Shunt
Optic Nerve Sheath Fenestration
Venous Sinus Stenting
Medication
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pseudotumor Cerebri Revenue
1.4 Market by Type
1.4.1 Global Pseudotumor Cerebri Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Fundoscopy
1.4.3 Neuroimaging
1.4.4 Lumbar Puncture
1.5 Market by Application
1.5.1 Global Pseudotumor Cerebri Market Share by Application: 2020 VS 2026
1.5.2 Spinal Fluid Shunt
1.5.3 Optic Nerve Sheath Fenestration
1.5.4 Venous Sinus Stenting
1.5.5 Medication
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pseudotumor Cerebri Market Perspective (2015-2026)
2.2 Global Pseudotumor Cerebri Growth Trends by Regions
2.2.1 Pseudotumor Cerebri Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pseudotumor Cerebri Historic Market Share by Regions (2015-2020)
2.2.3 Pseudotumor Cerebri Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pseudotumor Cerebri Market Growth Strategy
2.3.6 Primary Interviews with Key Pseudotumor Cerebri Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pseudotumor Cerebri Players by Market Size
3.1.1 Global Top Pseudotumor Cerebri Players by Revenue (2015-2020)
3.1.2 Global Pseudotumor Cerebri Revenue Market Share by Players (2015-2020)
3.1.3 Global Pseudotumor Cerebri Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pseudotumor Cerebri Market Concentration Ratio
3.2.1 Global Pseudotumor Cerebri Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pseudotumor Cerebri Revenue in 2019
3.3 Pseudotumor Cerebri Key Players Head office and Area Served
3.4 Key Players Pseudotumor Cerebri Product Solution and Service
3.5 Date of Enter into Pseudotumor Cerebri Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pseudotumor Cerebri Historic Market Size by Type (2015-2020)
4.2 Global Pseudotumor Cerebri Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pseudotumor Cerebri Market Size by Application (2015-2020)
5.2 Global Pseudotumor Cerebri Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pseudotumor Cerebri Market Size (2015-2020)
6.2 Pseudotumor Cerebri Key Players in North America (2019-2020)
6.3 North America Pseudotumor Cerebri Market Size by Type (2015-2020)
6.4 North America Pseudotumor Cerebri Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pseudotumor Cerebri Market Size (2015-2020)
7.2 Pseudotumor Cerebri Key Players in Europe (2019-2020)
7.3 Europe Pseudotumor Cerebri Market Size by Type (2015-2020)
7.4 Europe Pseudotumor Cerebri Market Size by Application (2015-2020)
8 China
8.1 China Pseudotumor Cerebri Market Size (2015-2020)
8.2 Pseudotumor Cerebri Key Players in China (2019-2020)
8.3 China Pseudotumor Cerebri Market Size by Type (2015-2020)
8.4 China Pseudotumor Cerebri Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pseudotumor Cerebri Market Size (2015-2020)
9.2 Pseudotumor Cerebri Key Players in Japan (2019-2020)
9.3 Japan Pseudotumor Cerebri Market Size by Type (2015-2020)
9.4 Japan Pseudotumor Cerebri Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pseudotumor Cerebri Market Size (2015-2020)
10.2 Pseudotumor Cerebri Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pseudotumor Cerebri Market Size by Type (2015-2020)
10.4 Southeast Asia Pseudotumor Cerebri Market Size by Application (2015-2020)
11 India
11.1 India Pseudotumor Cerebri Market Size (2015-2020)
11.2 Pseudotumor Cerebri Key Players in India (2019-2020)
11.3 India Pseudotumor Cerebri Market Size by Type (2015-2020)
11.4 India Pseudotumor Cerebri Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pseudotumor Cerebri Market Size (2015-2020)
12.2 Pseudotumor Cerebri Key Players in Central & South America (2019-2020)
12.3 Central & South America Pseudotumor Cerebri Market Size by Type (2015-2020)
12.4 Central & South America Pseudotumor Cerebri Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Avkare, Inc.
13.1.1 Avkare, Inc. Company Details
13.1.2 Avkare, Inc. Business Overview
13.1.3 Avkare, Inc. Pseudotumor Cerebri Introduction
13.1.4 Avkare, Inc. Revenue in Pseudotumor Cerebri Business (2015-2020))
13.1.5 Avkare, Inc. Recent Development
13.2 B. Braun Melsungen AG
13.2.1 B. Braun Melsungen AG Company Details
13.2.2 B. Braun Melsungen AG Business Overview
13.2.3 B. Braun Melsungen AG Pseudotumor Cerebri Introduction
13.2.4 B. Braun Melsungen AG Revenue in Pseudotumor Cerebri Business (2015-2020)
13.2.5 B. Braun Melsungen AG Recent Development
13.3 Beckersmith Medical, Inc.
13.3.1 Beckersmith Medical, Inc. Company Details
13.3.2 Beckersmith Medical, Inc. Business Overview
13.3.3 Beckersmith Medical, Inc. Pseudotumor Cerebri Introduction
13.3.4 Beckersmith Medical, Inc. Revenue in Pseudotumor Cerebri Business (2015-2020)
13.3.5 Beckersmith Medical, Inc. Recent Development
13.4 Elekta AB
13.4.1 Elekta AB Company Details
13.4.2 Elekta AB Business Overview
13.4.3 Elekta AB Pseudotumor Cerebri Introduction
13.4.4 Elekta AB Revenue in Pseudotumor Cerebri Business (2015-2020)
13.4.5 Elekta AB Recent Development
13.5 Heritage Pharmaceuticals Inc.
13.5.1 Heritage Pharmaceuticals Inc. Company Details
13.5.2 Heritage Pharmaceuticals Inc. Business Overview
13.5.3 Heritage Pharmaceuticals Inc. Pseudotumor Cerebri Introduction
13.5.4 Heritage Pharmaceuticals Inc. Revenue in Pseudotumor Cerebri Business (2015-2020)
13.5.5 Heritage Pharmaceuticals Inc. Recent Development
13.6 Ingenus Pharmaceuticals
13.6.1 Ingenus Pharmaceuticals Company Details
13.6.2 Ingenus Pharmaceuticals Business Overview
13.6.3 Ingenus Pharmaceuticals Pseudotumor Cerebri Introduction
13.6.4 Ingenus Pharmaceuticals Revenue in Pseudotumor Cerebri Business (2015-2020)
13.6.5 Ingenus Pharmaceuticals Recent Development
13.7 Integra LifeSciences Corporation
13.7.1 Integra LifeSciences Corporation Company Details
13.7.2 Integra LifeSciences Corporation Business Overview
13.7.3 Integra LifeSciences Corporation Pseudotumor Cerebri Introduction
13.7.4 Integra LifeSciences Corporation Revenue in Pseudotumor Cerebri Business (2015-2020)
13.7.5 Integra LifeSciences Corporation Recent Development
13.8 Johnson & Johnson Services, Inc.
13.8.1 Johnson & Johnson Services, Inc. Company Details
13.8.2 Johnson & Johnson Services, Inc. Business Overview
13.8.3 Johnson & Johnson Services, Inc. Pseudotumor Cerebri Introduction
13.8.4 Johnson & Johnson Services, Inc. Revenue in Pseudotumor Cerebri Business (2015-2020)
13.8.5 Johnson & Johnson Services, Inc. Recent Development
13.9 Lannett Company, Inc.
13.9.1 Lannett Company, Inc. Company Details
13.9.2 Lannett Company, Inc. Business Overview
13.9.3 Lannett Company, Inc. Pseudotumor Cerebri Introduction
13.9.4 Lannett Company, Inc. Revenue in Pseudotumor Cerebri Business (2015-2020)
13.9.5 Lannett Company, Inc. Recent Development
13.10 Magstim
13.10.1 Magstim Company Details
13.10.2 Magstim Business Overview
13.10.3 Magstim Pseudotumor Cerebri Introduction
13.10.4 Magstim Revenue in Pseudotumor Cerebri Business (2015-2020)
13.10.5 Magstim Recent Development
13.11 Medtronic
10.11.1 Medtronic Company Details
10.11.2 Medtronic Business Overview
10.11.3 Medtronic Pseudotumor Cerebri Introduction
10.11.4 Medtronic Revenue in Pseudotumor Cerebri Business (2015-2020)
10.11.5 Medtronic Recent Development
13.12 MercuryPharma
10.12.1 MercuryPharma Company Details
10.12.2 MercuryPharma Business Overview
10.12.3 MercuryPharma Pseudotumor Cerebri Introduction
10.12.4 MercuryPharma Revenue in Pseudotumor Cerebri Business (2015-2020)
10.12.5 MercuryPharma Recent Development
13.13 Nostrum Laboratories Inc.
10.13.1 Nostrum Laboratories Inc. Company Details
10.13.2 Nostrum Laboratories Inc. Business Overview
10.13.3 Nostrum Laboratories Inc. Pseudotumor Cerebri Introduction
10.13.4 Nostrum Laboratories Inc. Revenue in Pseudotumor Cerebri Business (2015-2020)
10.13.5 Nostrum Laboratories Inc. Recent Development
13.14 Novast Holdings Ltd.
10.14.1 Novast Holdings Ltd. Company Details
10.14.2 Novast Holdings Ltd. Business Overview
10.14.3 Novast Holdings Ltd. Pseudotumor Cerebri Introduction
10.14.4 Novast Holdings Ltd. Revenue in Pseudotumor Cerebri Business (2015-2020)
10.14.5 Novast Holdings Ltd. Recent Development
13.15 Phoenix Biomedical Corp.
10.15.1 Phoenix Biomedical Corp. Company Details
10.15.2 Phoenix Biomedical Corp. Business Overview
10.15.3 Phoenix Biomedical Corp. Pseudotumor Cerebri Introduction
10.15.4 Phoenix Biomedical Corp. Revenue in Pseudotumor Cerebri Business (2015-2020)
10.15.5 Phoenix Biomedical Corp. Recent Development
13.16 Sanofi, SGPharma Pvt. Ltd.
10.16.1 Sanofi, SGPharma Pvt. Ltd. Company Details
10.16.2 Sanofi, SGPharma Pvt. Ltd. Business Overview
10.16.3 Sanofi, SGPharma Pvt. Ltd. Pseudotumor Cerebri Introduction
10.16.4 Sanofi, SGPharma Pvt. Ltd. Revenue in Pseudotumor Cerebri Business (2015-2020)
10.16.5 Sanofi, SGPharma Pvt. Ltd. Recent Development
13.17 Sophysa
10.17.1 Sophysa Company Details
10.17.2 Sophysa Business Overview
10.17.3 Sophysa Pseudotumor Cerebri Introduction
10.17.4 Sophysa Revenue in Pseudotumor Cerebri Business (2015-2020)
10.17.5 Sophysa Recent Development
13.18 Taro Pharmaceutical Industries Ltd.
10.18.1 Taro Pharmaceutical Industries Ltd. Company Details
10.18.2 Taro Pharmaceutical Industries Ltd. Business Overview
10.18.3 Taro Pharmaceutical Industries Ltd. Pseudotumor Cerebri Introduction
10.18.4 Taro Pharmaceutical Industries Ltd. Revenue in Pseudotumor Cerebri Business (2015-2020)
10.18.5 Taro Pharmaceutical Industries Ltd. Recent Development
13.19 Teva Pharmaceutical Industries Ltd.
10.19.1 Teva Pharmaceutical Industries Ltd. Company Details
10.19.2 Teva Pharmaceutical Industries Ltd. Business Overview
10.19.3 Teva Pharmaceutical Industries Ltd. Pseudotumor Cerebri Introduction
10.19.4 Teva Pharmaceutical Industries Ltd. Revenue in Pseudotumor Cerebri Business (2015-2020)
10.19.5 Teva Pharmaceutical Industries Ltd. Recent Development
13.20 West-Ward Pharmaceutical
10.20.1 West-Ward Pharmaceutical Company Details
10.20.2 West-Ward Pharmaceutical Business Overview
10.20.3 West-Ward Pharmaceutical Pseudotumor Cerebri Introduction
10.20.4 West-Ward Pharmaceutical Revenue in Pseudotumor Cerebri Business (2015-2020)
10.20.5 West-Ward Pharmaceutical Recent Development
13.21 Zydus Pharmaceuticals, Inc.
10.21.1 Zydus Pharmaceuticals, Inc. Company Details
10.21.2 Zydus Pharmaceuticals, Inc. Business Overview
10.21.3 Zydus Pharmaceuticals, Inc. Pseudotumor Cerebri Introduction
10.21.4 Zydus Pharmaceuticals, Inc. Revenue in Pseudotumor Cerebri Business (2015-2020)
10.21.5 Zydus Pharmaceuticals, Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pseudotumor Cerebri Key Market Segments
Table 2. Key Players Covered: Ranking by Pseudotumor Cerebri Revenue
Table 3. Ranking of Global Top Pseudotumor Cerebri Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pseudotumor Cerebri Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fundoscopy
Table 6. Key Players of Neuroimaging
Table 7. Key Players of Lumbar Puncture
Table 8. Global Pseudotumor Cerebri Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Pseudotumor Cerebri Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Pseudotumor Cerebri Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Pseudotumor Cerebri Market Share by Regions (2015-2020)
Table 12. Global Pseudotumor Cerebri Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Pseudotumor Cerebri Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Pseudotumor Cerebri Market Growth Strategy
Table 18. Main Points Interviewed from Key Pseudotumor Cerebri Players
Table 19. Global Pseudotumor Cerebri Revenue by Players (2015-2020) (Million US$)
Table 20. Global Pseudotumor Cerebri Market Share by Players (2015-2020)
Table 21. Global Top Pseudotumor Cerebri Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudotumor Cerebri as of 2019)
Table 22. Global Pseudotumor Cerebri by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pseudotumor Cerebri Product Solution and Service
Table 25. Date of Enter into Pseudotumor Cerebri Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pseudotumor Cerebri Market Size by Type (2015-2020) (Million US$)
Table 28. Global Pseudotumor Cerebri Market Size Share by Type (2015-2020)
Table 29. Global Pseudotumor Cerebri Revenue Market Share by Type (2021-2026)
Table 30. Global Pseudotumor Cerebri Market Size Share by Application (2015-2020)
Table 31. Global Pseudotumor Cerebri Market Size by Application (2015-2020) (Million US$)
Table 32. Global Pseudotumor Cerebri Market Size Share by Application (2021-2026)
Table 33. North America Key Players Pseudotumor Cerebri Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Pseudotumor Cerebri Market Share (2019-2020)
Table 35. North America Pseudotumor Cerebri Market Size by Type (2015-2020) (Million US$)
Table 36. North America Pseudotumor Cerebri Market Share by Type (2015-2020)
Table 37. North America Pseudotumor Cerebri Market Size by Application (2015-2020) (Million US$)
Table 38. North America Pseudotumor Cerebri Market Share by Application (2015-2020)
Table 39. Europe Key Players Pseudotumor Cerebri Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Pseudotumor Cerebri Market Share (2019-2020)
Table 41. Europe Pseudotumor Cerebri Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Pseudotumor Cerebri Market Share by Type (2015-2020)
Table 43. Europe Pseudotumor Cerebri Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Pseudotumor Cerebri Market Share by Application (2015-2020)
Table 45. China Key Players Pseudotumor Cerebri Revenue (2019-2020) (Million US$)
Table 46. China Key Players Pseudotumor Cerebri Market Share (2019-2020)
Table 47. China Pseudotumor Cerebri Market Size by Type (2015-2020) (Million US$)
Table 48. China Pseudotumor Cerebri Market Share by Type (2015-2020)
Table 49. China Pseudotumor Cerebri Market Size by Application (2015-2020) (Million US$)
Table 50. China Pseudotumor Cerebri Market Share by Application (2015-2020)
Table 51. Japan Key Players Pseudotumor Cerebri Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Pseudotumor Cerebri Market Share (2019-2020)
Table 53. Japan Pseudotumor Cerebri Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Pseudotumor Cerebri Market Share by Type (2015-2020)
Table 55. Japan Pseudotumor Cerebri Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Pseudotumor Cerebri Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Pseudotumor Cerebri Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Pseudotumor Cerebri Market Share (2019-2020)
Table 59. Southeast Asia Pseudotumor Cerebri Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Pseudotumor Cerebri Market Share by Type (2015-2020)
Table 61. Southeast Asia Pseudotumor Cerebri Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Pseudotumor Cerebri Market Share by Application (2015-2020)
Table 63. India Key Players Pseudotumor Cerebri Revenue (2019-2020) (Million US$)
Table 64. India Key Players Pseudotumor Cerebri Market Share (2019-2020)
Table 65. India Pseudotumor Cerebri Market Size by Type (2015-2020) (Million US$)
Table 66. India Pseudotumor Cerebri Market Share by Type (2015-2020)
Table 67. India Pseudotumor Cerebri Market Size by Application (2015-2020) (Million US$)
Table 68. India Pseudotumor Cerebri Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Pseudotumor Cerebri Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Pseudotumor Cerebri Market Share (2019-2020)
Table 71. Central & South America Pseudotumor Cerebri Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Pseudotumor Cerebri Market Share by Type (2015-2020)
Table 73. Central & South America Pseudotumor Cerebri Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Pseudotumor Cerebri Market Share by Application (2015-2020)
Table 75. Avkare, Inc. Company Details
Table 76. Avkare, Inc. Business Overview
Table 77. Avkare, Inc. Product
Table 78. Avkare, Inc. Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 79. Avkare, Inc. Recent Development
Table 80. B. Braun Melsungen AG Company Details
Table 81. B. Braun Melsungen AG Business Overview
Table 82. B. Braun Melsungen AG Product
Table 83. B. Braun Melsungen AG Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 84. B. Braun Melsungen AG Recent Development
Table 85. Beckersmith Medical, Inc. Company Details
Table 86. Beckersmith Medical, Inc. Business Overview
Table 87. Beckersmith Medical, Inc. Product
Table 88. Beckersmith Medical, Inc. Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 89. Beckersmith Medical, Inc. Recent Development
Table 90. Elekta AB Company Details
Table 91. Elekta AB Business Overview
Table 92. Elekta AB Product
Table 93. Elekta AB Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 94. Elekta AB Recent Development
Table 95. Heritage Pharmaceuticals Inc. Company Details
Table 96. Heritage Pharmaceuticals Inc. Business Overview
Table 97. Heritage Pharmaceuticals Inc. Product
Table 98. Heritage Pharmaceuticals Inc. Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 99. Heritage Pharmaceuticals Inc. Recent Development
Table 100. Ingenus Pharmaceuticals Company Details
Table 101. Ingenus Pharmaceuticals Business Overview
Table 102. Ingenus Pharmaceuticals Product
Table 103. Ingenus Pharmaceuticals Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 104. Ingenus Pharmaceuticals Recent Development
Table 105. Integra LifeSciences Corporation Company Details
Table 106. Integra LifeSciences Corporation Business Overview
Table 107. Integra LifeSciences Corporation Product
Table 108. Integra LifeSciences Corporation Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 109. Integra LifeSciences Corporation Recent Development
Table 110. Johnson & Johnson Services, Inc. Business Overview
Table 111. Johnson & Johnson Services, Inc. Product
Table 112. Johnson & Johnson Services, Inc. Company Details
Table 113. Johnson & Johnson Services, Inc. Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 114. Johnson & Johnson Services, Inc. Recent Development
Table 115. Lannett Company, Inc. Company Details
Table 116. Lannett Company, Inc. Business Overview
Table 117. Lannett Company, Inc. Product
Table 118. Lannett Company, Inc. Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 119. Lannett Company, Inc. Recent Development
Table 120. Magstim Company Details
Table 121. Magstim Business Overview
Table 122. Magstim Product
Table 123. Magstim Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 124. Magstim Recent Development
Table 125. Medtronic Company Details
Table 126. Medtronic Business Overview
Table 127. Medtronic Product
Table 128. Medtronic Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 129. Medtronic Recent Development
Table 130. MercuryPharma Company Details
Table 131. MercuryPharma Business Overview
Table 132. MercuryPharma Product
Table 133. MercuryPharma Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 134. MercuryPharma Recent Development
Table 135. Nostrum Laboratories Inc. Company Details
Table 136. Nostrum Laboratories Inc. Business Overview
Table 137. Nostrum Laboratories Inc. Product
Table 138. Nostrum Laboratories Inc. Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 139. Nostrum Laboratories Inc. Recent Development
Table 140. Novast Holdings Ltd. Company Details
Table 141. Novast Holdings Ltd. Business Overview
Table 142. Novast Holdings Ltd. Product
Table 143. Novast Holdings Ltd. Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 144. Novast Holdings Ltd. Recent Development
Table 145. Phoenix Biomedical Corp. Company Details
Table 146. Phoenix Biomedical Corp. Business Overview
Table 147. Phoenix Biomedical Corp. Product
Table 148. Phoenix Biomedical Corp. Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 149. Phoenix Biomedical Corp. Recent Development
Table 150. Sanofi, SGPharma Pvt. Ltd. Company Details
Table 151. Sanofi, SGPharma Pvt. Ltd. Business Overview
Table 152. Sanofi, SGPharma Pvt. Ltd. Product
Table 153. Sanofi, SGPharma Pvt. Ltd. Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 154. Sanofi, SGPharma Pvt. Ltd. Recent Development
Table 155. Sophysa Company Details
Table 156. Sophysa Business Overview
Table 157. Sophysa Product
Table 158. Sophysa Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 159. Sophysa Recent Development
Table 160. Taro Pharmaceutical Industries Ltd. Company Details
Table 161. Taro Pharmaceutical Industries Ltd. Business Overview
Table 162. Taro Pharmaceutical Industries Ltd. Product
Table 163. Taro Pharmaceutical Industries Ltd. Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 164. Taro Pharmaceutical Industries Ltd. Recent Development
Table 165. Teva Pharmaceutical Industries Ltd. Company Details
Table 166. Teva Pharmaceutical Industries Ltd. Business Overview
Table 167. Teva Pharmaceutical Industries Ltd. Product
Table 168. Teva Pharmaceutical Industries Ltd. Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 169. Teva Pharmaceutical Industries Ltd. Recent Development
Table 170. West-Ward Pharmaceutical Company Details
Table 171. West-Ward Pharmaceutical Business Overview
Table 172. West-Ward Pharmaceutical Product
Table 173. West-Ward Pharmaceutical Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 174. West-Ward Pharmaceutical Recent Development
Table 175. Zydus Pharmaceuticals, Inc. Company Details
Table 176. Zydus Pharmaceuticals, Inc. Business Overview
Table 177. Zydus Pharmaceuticals, Inc. Product
Table 178. Zydus Pharmaceuticals, Inc. Revenue in Pseudotumor Cerebri Business (2015-2020) (Million US$)
Table 179. Zydus Pharmaceuticals, Inc. Recent Development
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pseudotumor Cerebri Market Share by Type: 2020 VS 2026
Figure 2. Fundoscopy Features
Figure 3. Neuroimaging Features
Figure 4. Lumbar Puncture Features
Figure 5. Global Pseudotumor Cerebri Market Share by Application: 2020 VS 2026
Figure 6. Spinal Fluid Shunt Case Studies
Figure 7. Optic Nerve Sheath Fenestration Case Studies
Figure 8. Venous Sinus Stenting Case Studies
Figure 9. Medication Case Studies
Figure 10. Pseudotumor Cerebri Report Years Considered
Figure 11. Global Pseudotumor Cerebri Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Pseudotumor Cerebri Market Share by Regions: 2020 VS 2026
Figure 13. Global Pseudotumor Cerebri Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pseudotumor Cerebri Market Share by Players in 2019
Figure 16. Global Top Pseudotumor Cerebri Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudotumor Cerebri as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Pseudotumor Cerebri Revenue in 2019
Figure 18. North America Pseudotumor Cerebri Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Pseudotumor Cerebri Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Pseudotumor Cerebri Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Pseudotumor Cerebri Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Pseudotumor Cerebri Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Pseudotumor Cerebri Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Pseudotumor Cerebri Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
視神経膠腫の世界市場（～2026年） An optic nerve glioma is a type of brain tumor. There are multiple kinds of brain tumors. Typically, each type of tumor is named after the kinds of cells it affects. Most optic nerve gliomas are considered low-grade and don’t grow as quickly as other types of brain tumors. They are found in the opti…- 脳脊髄液（CSF）管理の世界市場（～2026年） CSF is a clear, colorless body fluid found in the brain and spinal cord. CSF occupies the subarachnoid space (between the arachnoid mater and the pia mater) and the ventricular system around and inside the brain and spinal cord. Market Analysis and Insights: Global Cerebral Spinal Fluid (CSF) Manage…
- 腰椎固定術の世界市場（～2026年） Spinal fusion surgery is performed in many forms, and all are designed to help limit the pain caused by joints through surgery depending on conditions such as degenerative disc disease (DDD), spondylosyndesis or spondylodesis, and other small problems caused in spine vertebrae. Over the recent years…
- 静脈-静脈ECMOシステムの世界市場（～2026年） Market Analysis and Insights: Global Veno-Venous ECMO System Market The global Veno-Venous ECMO System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veno-Venous ECMO System Scope and Market Size Veno-Venous ECMO Syst…
- 副鼻腔治療薬の世界市場（～2026年） Market Analysis and Insights: Global Sinus Therapeutic Drug Market The global Sinus Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…